Entrada Therapeutics, Inc. (TRDA)
NASDAQ·Healthcare·Biotechnology
$4.42
—
Mkt Cap $274.07M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$14.00
Range $11.00 – $17.00
Implied Upside
+216.7%
Consensus $14.00 vs current $4.42
NASDAQ·Healthcare·Biotechnology
$4.42
—
Mkt Cap $274.07M
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$14.00
Range $11.00 – $17.00
+216.7%
Consensus $14.00 vs current $4.42